Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1974-05-30
1982-03-23
Jiles, Henry R.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
424308, 424343, 542414, 542416, 542420, 542426, 2603472, 2603473, 2603474, 560 9, 560 10, 560 11, 560 45, 560 53, 560 56, 560 55, 562427, 562429, 562426, 562452, 562462, 562463, 562465, 562466, 568 37, 568 42, 568 47, 568330, 568631, A61K 31557
Patent
active
043212751
ABSTRACT:
The disclosure relates to novel 17,18,19,20-tetranor-prostanoic acid derivatives having prostaglandin-type properties, to a method for their manufacture, and also to pharmaceutical or veterinary compositions containing said novel derivatives and a method of inducing luteolysis in an animal host by use of said novel derivatives.
REFERENCES:
patent: 3833612 (1974-09-01), Wendler et al.
Bowler Jean
Crossley Neville S.
Dentz Bernard
Imperial Chemical Industries Limited
Jiles Henry R.
LandOfFree
Method of inducing luteolysis using 16-aryloxy-17,18,19,20-tetra does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of inducing luteolysis using 16-aryloxy-17,18,19,20-tetra, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of inducing luteolysis using 16-aryloxy-17,18,19,20-tetra will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1650846